Transitioning to E-Cigarettes Aids Resolution of Respiratory Symptoms
By Elana Gotkine HealthDay Reporter
TUESDAY, Nov. 12, 2024 -- Transitioning from cigarettes to electronic cigarettes (e-cigarettes) is associated with resolution of respiratory symptoms, but the rate of resolution is reduced among those who switch to dual use or maintain or increase smoking intensity, according to a study published online Nov. 12 in Nicotine & Tobacco Research.
Jonathan B. Berlowitz, M.D., from the Boston University School of Public Health, and colleagues examined whether transitioning from cigarettes to e-cigarettes is associated with resolution of respiratory symptoms using data from the Population Assessment of Tobacco and Health (PATH) study waves 1 to 5. Observations with cigarette−e-cigarette exposure intervals determined from PATH waves 1 to 2, 2 to 3, and 3 to 4 were included for participants who reported exclusively smoking at baseline and reported a baseline cough or wheeze.
The researchers found that compared with persistent smoking, transitioning from cigarettes to e-cigarettes was associated with increased rates of wheeze resolution (incidence rate ratio, 1.33; 95 percent confidence interval, 1.01 to 1.75), but not with cough resolution (incidence rate ratio, 1.18; 95 percent confidence interval, 0.93 to 1.50) among 5,210 observations. There was no association seen for cigarette to dual-use transitions with improvements in symptom resolution. Compared with persistent smoking, whose who switched to dual use and maintained or increased their smoking intensity had 15 percent reduced rates of respiratory symptom resolution.
"Whereas cigarette users who switch completely to e-cigarettes may experience respiratory symptom improvements, those unable to reduce their smoking intensity may face increased risk of respiratory morbidity," the authors write. "This difference is concerning as U.S. cigarette users are far more likely to transition to dual use than to exclusive e-cigarette use."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Methotrexate Noninferior to Prednisone in Pulmonary Sarcoidosis
TUESDAY, May 20, 2025 -- For patients with pulmonary sarcoidosis, methotrexate is noninferior to prednisone with regard to the change from baseline to week 24 in the percentage of...
Nicotine Pouch Use in Teens Linked to Lower Risk for Continued Vaping
MONDAY, May 19, 2025 -- Nicotine pouch use in adolescence is associated with a lower likelihood of continued vaping, according to a study published online May 19 in...
Use of Composite Allocation Score for Lung Transplant Wait List Improves Outcomes
MONDAY, May 19, 2025 -- Wait-list outcomes for lung transplants have substantially improved in the composite allocation score (CAS) era, according to a study presented at the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.